MX2009006650A - Pirimidinas substituidas que contienen una porcion heteroarilamida o heteroarilfenilo. - Google Patents

Pirimidinas substituidas que contienen una porcion heteroarilamida o heteroarilfenilo.

Info

Publication number
MX2009006650A
MX2009006650A MX2009006650A MX2009006650A MX2009006650A MX 2009006650 A MX2009006650 A MX 2009006650A MX 2009006650 A MX2009006650 A MX 2009006650A MX 2009006650 A MX2009006650 A MX 2009006650A MX 2009006650 A MX2009006650 A MX 2009006650A
Authority
MX
Mexico
Prior art keywords
heteroarylphenyl
heteroarylamide
moiety
substituted piperidines
group
Prior art date
Application number
MX2009006650A
Other languages
English (en)
Inventor
Richard William Arthur Luke
Marinus Leendert Verdonk
Steven John Woodhead
Hannah Fiona Sore
David Winter Walker
Ian Collins
Zbigniew Stanley Matusiak
Christopher Hamlett
Tatiana Faria Da Fonseca Mchardy
Gregory Richard Carr
Jeffrey James Morris
Kwai Ming Cheung
Original Assignee
Astex Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0625682A external-priority patent/GB0625682D0/en
Application filed by Astex Therapeutics Ltd filed Critical Astex Therapeutics Ltd
Publication of MX2009006650A publication Critical patent/MX2009006650A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención proporciona compuestos de la fórmula (I) que tienen compuestos inhibidores de PKA o PKB cinasa de la fórmula (I): GP 1 J T 2 J N 4 R N H (I) o sales, solvatos, tautómeros o N-óxidos de los mismos, en donde (1) GP es un grupo GP1; HET 2a a Q G (HNCO)f 7 (R )x N * (GP1) (2) GP es un grupo GP2: 10 (R)r O 2a a QG (CH2)w N y H N * (GP2), en donde HET es un grupo heterocíclico monocíclico o bicíclico que contiene hasta 4 miembros de anti de átomo heterogéneo; el anillo y es un grupo heteroarilo monocíclico o bicíclico de 5 a 10 miembros de anillo; y JI, J2, R4, R7, RI0, Q2a, Ga, x, w y f son como se define en las reivindicaciones.
MX2009006650A 2006-12-21 2007-12-20 Pirimidinas substituidas que contienen una porcion heteroarilamida o heteroarilfenilo. MX2009006650A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87135506P 2006-12-21 2006-12-21
GB0625682A GB0625682D0 (en) 2006-12-21 2006-12-21 Pharmaceutical compounds
US98263607P 2007-10-25 2007-10-25
US98615007P 2007-11-07 2007-11-07
PCT/GB2007/050777 WO2008075110A1 (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety

Publications (1)

Publication Number Publication Date
MX2009006650A true MX2009006650A (es) 2009-08-20

Family

ID=39301245

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006650A MX2009006650A (es) 2006-12-21 2007-12-20 Pirimidinas substituidas que contienen una porcion heteroarilamida o heteroarilfenilo.

Country Status (15)

Country Link
US (1) US20100120798A1 (es)
EP (1) EP2125820A1 (es)
JP (1) JP2010513453A (es)
KR (1) KR20090104030A (es)
AR (1) AR064415A1 (es)
AU (1) AU2007335969A1 (es)
BR (1) BRPI0721124A2 (es)
CA (1) CA2672841A1 (es)
EC (1) ECSP099446A (es)
MX (1) MX2009006650A (es)
NO (1) NO20092341L (es)
PE (1) PE20081680A1 (es)
TW (1) TW200833694A (es)
UY (1) UY30823A1 (es)
WO (1) WO2008075110A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
US8796293B2 (en) 2006-04-25 2014-08-05 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
KR101494734B1 (ko) 2007-10-11 2015-02-26 아스트라제네카 아베 단백질 키나제 ｂ 억제제로서 피롤로[2,3-ｄ]피리미딘 유도체
EP2297153B1 (en) * 2008-04-21 2015-05-27 Lexicon Pharmaceuticals, Inc. Limk2 inhibitors, compositions comprising them, and methods of their use
ES2617339T3 (es) 2010-12-16 2017-06-16 Calchan Limited Derivados de pirrolopirimidina inhibidores de ASK1
WO2012131399A1 (en) 2011-04-01 2012-10-04 Astrazeneca Ab Therapeutic treatment
UA110259C2 (uk) 2011-09-22 2015-12-10 Пфайзер Інк. Похідні піролопіримідину і пурину
EP2785349B2 (en) 2011-11-30 2022-11-09 Astrazeneca AB Combination treatment of cancer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
CN104119342A (zh) * 2013-04-25 2014-10-29 苏州科捷生物医药有限公司 一种制备高纯度4-氯-5-甲基-7H-吡咯[2,3-d]嘧啶的方法
EP3980417B1 (en) 2019-06-10 2023-09-27 Lupin Limited Prmt5 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1750727A2 (en) * 2004-04-23 2007-02-14 Exelixis, Inc. Kinase modulators and methods of use
MY179032A (en) * 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
US7994172B2 (en) * 2004-12-28 2011-08-09 Exelixis, Inc. [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
JP2009534456A (ja) * 2006-04-25 2009-09-24 アステックス、セラピューティックス、リミテッド 医薬化合物
WO2007125320A1 (en) * 2006-04-25 2007-11-08 Astex Therapeutics Limited Pharmaceutical compounds
JP2009536620A (ja) * 2006-04-25 2009-10-15 アステックス、セラピューティックス、リミテッド 医薬組み合わせ物

Also Published As

Publication number Publication date
KR20090104030A (ko) 2009-10-05
BRPI0721124A2 (pt) 2014-03-04
UY30823A1 (es) 2008-07-31
ECSP099446A (es) 2009-09-29
TW200833694A (en) 2008-08-16
AR064415A1 (es) 2009-04-01
WO2008075110A1 (en) 2008-06-26
JP2010513453A (ja) 2010-04-30
CA2672841A1 (en) 2008-06-26
PE20081680A1 (es) 2008-12-18
AU2007335969A1 (en) 2008-06-26
US20100120798A1 (en) 2010-05-13
EP2125820A1 (en) 2009-12-02
NO20092341L (no) 2009-07-21

Similar Documents

Publication Publication Date Title
MX2009006650A (es) Pirimidinas substituidas que contienen una porcion heteroarilamida o heteroarilfenilo.
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
SG162805A1 (en) Pyrazine derivatives useful as adenosine receptor antagonists
WO2007149448A3 (en) Pyrazinones as cellular proliferation inhibitors
MX2010000658A (es) Derivados de pirimidina 934.
WO2006123165A3 (en) Pyrimidine derivatives as hsp90 inhibitors
TW200732306A (en) Pyrimidine derivatives
DE602006007012D1 (de) Pyridinderivate als dipeptedyl-peptidase-hemmer
IN2014DN06567A (es)
WO2009109991A3 (en) Novel hydrazide containing tyrosine kinase inhibitors
NO20071073L (no) Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
TW200633991A (en) Chemical compounds
WO2006047479A3 (en) C-fms kinase inhibitors
BRPI0413233A (pt) novos compostos
WO2005076990A3 (en) Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
BRPI0519288A2 (pt) compostos heterocÍclicos como antagonistas de ccr2b
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
NO20075384L (no) Tiadiazolsubstituerte kumarinderivater og deres anvendelse som leukotrienbiosynteseinhibitorer.
MX2009005217A (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos.
AR076798A1 (es) Pirazinilpirazoles y composiciones que comprenden dichos compuestos
BRPI0510335A (pt) composto heterocìclico
MX2012006696A (es) Derivados de 3, 4, 4a, 10b-tetrahidro-1h-tiopirano-[4, 3-c]-isoqunolina.
PT1893589E (pt) Derivados substituídos de n-benzo[d]isoxazol-3-il-amina como inibidores de recetores mglur5, recetores de serotonina-(5-ht) e recetores de noradrenalina e sua utilização na produção de medicamentos
TW200628153A (en) Novel compounds
MY161992A (en) Novel tetrahydroisoquinoline derivative

Legal Events

Date Code Title Description
FA Abandonment or withdrawal